Mitoxantrone is approved for use in several types of cancer, including breast cancer, prostate cancer, and certain types of leukemia and lymphoma. It is particularly effective in treating advanced prostate cancer that is resistant to hormone therapy, often in combination with other drugs like prednisone. Additionally, it has applications in managing acute myeloid leukemia (AML) in adults.
